Habronemiasis (Summer Sores - Eyelid)

Habronemiasis, commonly known as summer sores, is a parasitic condition caused by aberrant migration of Habronema and Draschia stomach worm larvae deposited in wounds or moist body areas by infected flies. When larvae are deposited in the periocular region, they trigger an intense inflammatory and hypersensitivity reaction creating characteristic granulomatous lesions that can severely affect the eyelids, conjunctiva, and surrounding tissues. The condition derives its common name from its seasonal occurrence during warm months when fly populations peak, though lesions may persist or recur throughout the year in endemic areas with prolonged warm seasons.

Periocular habronemiasis affects horses in virtually all geographic regions where Habronema species and their fly intermediate hosts exist, with highest prevalence in warm, humid climates supporting year-round fly activity. The condition occurs across all ages and breeds, though individual hypersensitivity responses vary significantly, with some horses demonstrating marked susceptibility while others exposed to similar conditions remain unaffected. The medial canthus represents the most commonly affected periocular site due to its moist environment from tear accumulation, though any periocular tissue can be affected when larvae are deposited by feeding flies.

The impact of periocular habronemiasis on equine health ranges from mild localized irritation to severe, disfiguring granulomatous masses that threaten vision and eyelid function. The intense inflammatory response to larval presence creates tissue destruction and granuloma formation that progressively enlarges without treatment. Affected horses experience significant discomfort, with constant irritation, discharge, and pruritus affecting quality of life. Performance may be impacted by visual obstruction, headshaking, and behavioral changes associated with chronic ocular irritation. Secondary bacterial infection of lesions further complicates the disease course.

Fortunately, habronemiasis is highly treatable when diagnosed correctly and managed aggressively, with most cases resolving with appropriate therapy. Treatment success depends on eliminating the parasite through systemic anthelmintic administration, reducing inflammation through corticosteroid therapy, and maintaining fly control to prevent reinfection. Early intervention produces better outcomes with faster resolution and less residual scarring. Owner recognition of early lesions during fly season and prompt veterinary consultation prevents progression to advanced disease requiring more intensive management. Prevention through comprehensive fly control and regular deworming programs reduces incidence in at-risk populations.

The primary cause of habronemiasis involves aberrant parasitic life cycle completion by Habronema muscae, Habronema majus, and Draschia megastoma stomach worms. In the normal life cycle, larvae develop in fly intermediate hosts including house flies and stable flies, then are deposited around the horse's mouth during fly feeding. When swallowed, larvae mature in the stomach where adult worms cause minimal pathology in most horses. However, when infected flies deposit larvae in wounds, moist skin areas, or body orifices rather than the oral cavity, larvae cannot complete their development and instead trigger intense hypersensitivity reactions creating the characteristic granulomatous lesions of cutaneous habronemiasis.

The periocular region's vulnerability to habronemiasis relates to its attractiveness to feeding flies and the presence of conditions favoring larval survival. Flies are attracted to moist areas including the medial canthus where tears collect, existing wounds or irritations around the eyes, and any discharge that provides moisture. Once deposited, larvae cannot penetrate intact skin but readily enter through wounds, abrasions, or the moist mucous membranes of the conjunctiva. The warm, moist periocular environment supports larval survival while the horse's immune response attempts to destroy the foreign organisms, creating the destructive inflammatory cascade characteristic of the disease.

Environmental and management factors significantly influence habronemiasis risk through their effects on fly populations and larval exposure. Geographic regions with warm, humid climates support larger fly populations for longer seasons, increasing transmission opportunities. Farms with poor manure management provide breeding sites for intermediate host flies, while inadequate fly control measures allow high fly densities around horses. Horses housed in areas with standing water, wet bedding, or poor drainage face increased fly exposure. Wounds or existing ocular conditions that attract flies create portals of entry for larvae. Management practices that minimize fly breeding and contact directly reduce habronemiasis incidence.

Risk factors for developing periocular habronemiasis include environmental exposure, existing ocular conditions, and individual host responses. Horses living in fly-endemic areas during warm months face continuous exposure to infected flies. Those with pre-existing wounds, conjunctivitis, or other ocular abnormalities have increased vulnerability as larvae enter compromised tissues more readily. Individual variation in hypersensitivity responses means some horses develop severe lesions from minimal larval exposure while others tolerate similar exposure without clinical disease. Gray horses and those with pink skin around the eyes may experience more obvious lesions due to lack of pigmentation camouflaging early changes. Horses with previous habronemiasis lesions often develop recurrent disease at the same sites.

The pathophysiology of periocular habronemiasis involves complex host-parasite interactions creating characteristic tissue changes. When larvae enter periocular tissues, the host's immune system recognizes foreign proteins and mounts an aggressive inflammatory response. Type I and Type IV hypersensitivity reactions drive intense infiltration of eosinophils, mast cells, and other inflammatory cells. Unable to eliminate the persistent larval antigens, the immune response becomes chronic, with granulomatous inflammation, tissue necrosis, and formation of caseous material containing degenerating larvae and inflammatory debris. The characteristic yellow-white calcified granules or rice grain-like material within lesions represents this accumulated necrotic debris. Untreated lesions continue expanding as the inflammatory cycle perpetuates.

Early warning signs of periocular habronemiasis may be subtle and easily overlooked during initial stages. Small areas of reddening, mild swelling, or irritation at the medial canthus or along the eyelid margins represent early manifestations often dismissed as minor irritation or fly bite reactions. Increased tear production affecting one eye, mild crusty accumulations at the medial canthus, or slight behavioral changes suggesting ocular discomfort may precede obvious lesion development. Horses in endemic areas during fly season warrant careful daily examination for these early changes, as prompt treatment at this stage produces the best outcomes with minimal scarring.

Common symptoms of established periocular habronemiasis become increasingly apparent as lesions enlarge. Affected areas develop raised, reddened, ulcerated masses with a granular or cobblestone surface texture. Profuse serosanguinous or purulent discharge often accompanies active lesions, attracting additional flies and potentially extending lesion size. The characteristic yellow-white, caseous granules or rice grain-like material may be visible within the ulcerated tissue or discharge. Surrounding tissue edema and inflammation create swelling that may partially or completely obscure the eye. The medial canthus remains the most commonly affected site, though lesions can extend to involve the eyelids, conjunctiva, and periocular skin.

Behavioral changes associated with periocular habronemiasis reflect the significant irritation and pruritus caused by these lesions. Affected horses frequently rub their faces against objects, stall walls, fencing, or their forelimbs attempting to relieve itching. Head shaking, particularly when flies are present, becomes pronounced. Horses may resist handling around the face and become head-shy during grooming or bridling. Squinting, increased blinking, and obvious discomfort when exposed to bright light develop as lesion size increases. Some horses demonstrate depression, reduced appetite, or withdrawal from normal activities due to chronic discomfort. The constant irritation affects performance, with horses showing resistance to work or inability to concentrate during riding.

Physical signs visible upon examination vary with lesion stage and severity. Active lesions appear as raised, irregular, ulcerated masses with granular surfaces oozing serosanguinous fluid. The tissue is friable and bleeds easily when manipulated. Multiple small yellow-white granules resembling sulfur granules or rice grains may be expressed from the lesion, representing caseous debris containing degenerating larvae and inflammatory cells. Surrounding tissues show erythema, edema, and in chronic cases, hair loss and skin thickening. Secondary bacterial infection produces purulent discharge and exacerbates inflammation. Conjunctival involvement appears as chemosis, hyperemia, and granulomatous masses on the conjunctival surfaces.

Symptom progression in untreated habronemiasis follows a pattern of continued expansion and increasing inflammation. Early lesions enlarge progressively as the hypersensitivity reaction expands outward from initial larval deposition sites. Ulceration deepens and widens, with proud flesh-like granulation tissue proliferating from wound beds. Severe cases develop extensive tissue destruction affecting eyelid structure and function. The intense pruritus leads to self-trauma that worsens lesions and introduces secondary infection. Lesions may eventually stabilize or partially regress during cooler months when fly activity decreases, only to recur or expand with renewed fly exposure the following season.

Emergency symptoms requiring immediate veterinary care include rapid lesion expansion threatening eyelid integrity, development of corneal involvement with ulceration or opacity, signs of secondary bacterial infection including fever and purulent discharge, or extreme discomfort suggesting severe inflammation. Any periocular mass that fails to respond to initial treatment or shows unusual characteristics requires veterinary reassessment and possible biopsy to confirm diagnosis and rule out neoplasia. Horses demonstrating severe pruritus with uncontrolled self-trauma need urgent intervention to prevent further damage. Globe involvement evidenced by changes in eye appearance warrants immediate evaluation.

Physical examination for suspected periocular habronemiasis begins with assessment of lesion characteristics in the context of history and environmental factors. The seasonal occurrence during warm months, geographic location in fly-endemic regions, and characteristic lesion appearance provide strong clinical suspicion for the diagnosis. The veterinarian evaluates lesion location, noting predilection for the medial canthus and moist tissue areas. Surface characteristics including ulceration, granular texture, and presence of caseous granules support the clinical diagnosis. Complete ophthalmic examination assesses corneal involvement, conjunctival changes, and any effect on globe integrity or visual function.

Diagnostic tests confirming habronemiasis rely primarily on identification of characteristic lesion contents and tissue changes. Expression of yellow-white caseous granules from the lesion provides presumptive diagnosis when these characteristic structures are identified. Cytologic examination of expressed material or tissue impressions may reveal degenerating larvae, larval fragments, or the characteristic eosinophilic inflammatory response. Histopathologic examination of biopsy tissue demonstrates granulomatous inflammation with eosinophils, necrotic debris, and potentially identifiable larval sections, providing definitive diagnosis. The intense eosinophilic response differentiates habronemiasis from other granulomatous conditions.

Advanced diagnostics become necessary when clinical presentation is atypical or when response to standard treatment is inadequate. Biopsy with histopathologic examination provides definitive diagnosis while excluding neoplastic conditions that may mimic habronemiasis, particularly squamous cell carcinoma which can appear similar clinically. Culture and sensitivity testing of discharge identifies bacterial pathogens in secondarily infected lesions, guiding antimicrobial selection. Complete ophthalmic examination including fluorescein staining documents corneal involvement requiring concurrent management. In horses with systemic signs, complete blood count may reveal eosinophilia supporting parasitic etiology, though this finding is inconsistent.

Differential diagnosis for periocular granulomatous lesions includes several important conditions requiring distinction from habronemiasis. Squamous cell carcinoma represents the most critical differential, as this malignancy shares the ulcerated, granular appearance and periocular predilection of habronemiasis. Sarcoids, particularly fibroblastic forms, create proud flesh-like masses that may be confused with summer sores. Proud flesh from previous trauma presents as exuberant granulation tissue mimicking habronemiasis in wounds. Pythiosis creates similar granulomatous lesions with caseous material, occurring in similar geographic and environmental conditions. Bacterial or fungal granulomas, foreign body reactions, and eosinophilic granulomas require histopathologic differentiation. The characteristic caseous granules of habronemiasis and histopathologic identification of larvae or larval fragments confirm the diagnosis when clinical presentation alone is insufficient.

Emergency and immediate treatment for periocular habronemiasis addresses acute inflammation while initiating antiparasitic therapy. Systemic ivermectin or moxidectin administration provides larvicidal activity, though dead larvae may initially intensify inflammation before resolution occurs. Concurrent systemic anti-inflammatory therapy using corticosteroids or non-steroidal anti-inflammatory drugs reduces the hypersensitivity response driving tissue damage. Topical corticosteroid therapy applied directly to lesions provides localized anti-inflammatory effect. Eye protection using fly masks with fine mesh prevents additional larval deposition while shields against self-trauma. The horse should be moved to an environment with reduced fly exposure if possible.

Medical management forms the foundation of habronemiasis treatment, with multiple therapeutic modalities addressing different aspects of disease pathogenesis. Systemic anthelmintic therapy continues with repeated dosing at two to three week intervals until lesion resolution, as larvae present in tissues may not be eliminated by single treatment. Organophosphate compounds applied topically provide direct larvicidal activity at the lesion site. Systemic corticosteroids reduce the intense inflammatory and hypersensitivity responses perpetuating tissue damage, with dosing tapered as lesions resolve. Topical corticosteroid-antibiotic combinations address both inflammation and secondary bacterial infection. DMSO may enhance drug penetration and provide additional anti-inflammatory effect.

Surgical intervention becomes necessary for large, unresponsive, or disfiguring lesions. Debulking of excessive granulation tissue reduces lesion burden and removes tissue harboring larvae and necrotic debris. Sharp excision or laser ablation of granulomatous masses provides definitive tissue removal with submission for histopathology confirming diagnosis. Cryotherapy applied to lesion beds following debulking destroys remaining abnormal tissue. Surgical intervention typically accompanies ongoing medical therapy rather than replacing it, as the underlying hypersensitivity reaction requires pharmacologic management. Care must be taken to protect the globe during surgical procedures in the periocular region, and reconstruction may be necessary for lesions causing significant tissue loss.

Supportive care throughout treatment emphasizes environmental management and wound care. Aggressive fly control reduces exposure to infected intermediate hosts, decreasing risk of additional larval deposition and lesion extension. Fly masks should remain in place continuously during daylight hours, with mesh fine enough to exclude flies from contact with periocular tissues. Wound care includes gentle cleaning of lesion surfaces to remove accumulated discharge and debris. Topical medications should be applied as directed, with care taken to avoid contaminating the eye itself. The horse's environment should be optimized to minimize fly populations through manure management, elimination of standing water, and use of premise fly control measures.

Rehabilitation and return to work proceeds as lesions resolve and comfort improves. Gradual reduction of corticosteroid therapy follows established tapering protocols to prevent rebound inflammation. Continued fly protection remains essential even as lesions heal, as scarred areas may be vulnerable to recurrence. Return to work can proceed as comfort allows, though activities that generate significant fly exposure should be avoided until resolution is complete. Horses may require ongoing topical therapy to maintain lesion quiescence. Competition horses must observe withdrawal times for any medications used before returning to regulated activities.

Treatment decision factors influencing management approach include lesion extent, duration, previous treatment history, and seasonal timing. Early, small lesions often respond rapidly to medical management alone. Established, large lesions typically require more intensive multimodal therapy potentially including surgical debulking. Recurrent lesions at previously affected sites may respond less completely and require extended treatment courses. Treatment initiated during active fly season must account for ongoing exposure risk, while treatment during cooler months benefits from reduced reinfection pressure. Owner factors including ability to maintain intensive fly control, medication compliance capability, and financial considerations affect treatment planning and prognosis.

Recovery timeline for periocular habronemiasis varies based on lesion severity, treatment intensity, and environmental factors affecting reinfection risk. Small, early lesions treated aggressively may resolve within two to four weeks of initiating therapy. Moderate lesions typically require six to twelve weeks for complete resolution. Large, chronic, or surgically debrided lesions may need three months or longer for full healing with tissue remodeling continuing for months afterward. Lesions treated during seasons with reduced fly activity generally resolve more rapidly than those managed during peak fly season due to decreased reinfection pressure.

Post-treatment care and monitoring requirements extend beyond initial lesion resolution. Continued fly protection remains essential throughout the remainder of fly season to prevent recurrence at healing sites. Topical maintenance therapy may be indicated for areas showing incomplete resolution or tendency toward recurrence. Regular inspection of previously affected areas identifies early recurrence amenable to prompt retreatment. Monitoring of the entire horse for lesions at other body sites commonly affected by habronemiasis ensures comprehensive management. Adjustments to environmental management and fly control practices prevent future episodes.

Prognosis factors affecting outcomes include timing of treatment initiation, lesion characteristics, environmental control success, and individual host response patterns. Early treatment of small lesions carries excellent prognosis for complete resolution without significant scarring. Delayed treatment of advanced lesions results in more prolonged recovery with greater likelihood of residual scarring or tissue distortion. Success of fly control measures significantly influences both initial response and recurrence risk. Horses demonstrating intense hypersensitivity responses to habronemiasis may experience recurrence despite appropriate treatment, requiring ongoing vigilance and possibly prophylactic management during fly seasons.

Long-term outlook for horses recovering from periocular habronemiasis is generally favorable with appropriate management, though the condition's tendency for recurrence requires ongoing attention. Most horses achieve complete resolution of active lesions and return to full function. Scarring from healed lesions may persist but rarely causes functional impairment. Horses with history of periocular habronemiasis remain at increased risk for recurrence at previous sites or development of new lesions, necessitating enhanced fly protection and surveillance during future fly seasons. Some horses require seasonal prophylactic treatment to prevent recurrence. Quality of life remains excellent for properly managed horses, with the primary ongoing impact being the need for sustained preventive measures.

Management practices aimed at preventing periocular habronemiasis center on comprehensive fly control programs. Manure management through regular stall cleaning and composting or removal of manure piles eliminates breeding sites for intermediate host flies. Standing water sources should be drained or managed to prevent fly breeding. Premise fly control using traps, baits, and premise sprays reduces overall fly populations. Feed storage practices should minimize fly attraction and breeding in feed areas. Regular facility maintenance eliminates areas where organic matter accumulates and supports fly development. These environmental measures form the foundation of habronemiasis prevention by reducing the infected fly population that transmits larvae to horses.

Nutritional considerations for habronemiasis prevention relate to maintaining skin and immune system health that may influence susceptibility. Balanced nutrition supporting overall health optimizes the horse's ability to respond appropriately to parasitic exposure. Omega fatty acid supplementation may support skin barrier function and appropriate inflammatory responses. Adequate protein, vitamin, and mineral nutrition supports tissue repair when exposure does occur. No specific nutritional interventions have proven efficacy for preventing habronemiasis specifically, making general nutritional optimization the recommended approach within comprehensive prevention programs.

Exercise and conditioning contribute to prevention indirectly through effects on overall health and management practices. Fit horses maintained in appropriate condition demonstrate better immune function than those that are debilitated. Exercise schedules should consider fly activity patterns, with riding during periods of lower fly density reducing exposure during vulnerable times. Cleaning horses after exercise removes sweat and debris that attract flies. Training programs should avoid creating wounds or abrasions that provide entry sites for larvae. Washing and thoroughly drying periocular areas after exercise removes accumulated moisture attractive to flies.

Environmental factors beyond premise management influence individual horse exposure levels. Pasture selection considering fly density can reduce exposure, as some areas support higher fly populations than others. Shelter availability allows horses to escape fly pressure during peak activity periods. Strategic placement of water and feeding stations away from fly breeding areas reduces exposure during vulnerable activities. Trees and brush providing shade also harbor flies, making sunny, open areas potentially preferable despite reduced comfort during hot weather. Geographic considerations affect overall risk, with horses in warm, humid regions requiring more intensive prevention programs than those in drier or cooler climates.

Vaccination and deworming protocols directly address the parasites responsible for habronemiasis. Regular deworming with ivermectin or moxidectin maintains low gastric Habronema burdens in the horse population, reducing the number of larvae available for transmission. Strategic deworming during fly season, potentially at more frequent intervals than standard programs, maximizes impact on the parasitic life cycle. While no vaccine exists for habronemiasis prevention, maintaining current vaccinations supports overall health. Fly control products applied directly to horses, including fly sprays, pour-ons, and fly sheets or masks, provide individual protection supplementing environmental management measures.

Daily management adjustments for horses with active habronemiasis or history of the condition require consistent attention to fly protection and lesion monitoring. Fly masks should be applied every morning before turnout and remain in place until horses are stabled in fly-reduced environments. Masks require daily inspection for proper fit and integrity, with replacement as needed when damaged or worn. Affected areas should be examined daily for signs of lesion expansion, recurrence at healed sites, or development of new lesions. Medication schedules must be maintained precisely, with topical medications applied as directed without contaminating the eye itself. Any changes in lesion appearance or horse comfort level should be documented and reported to the veterinarian.

Housing and turnout considerations during active disease and ongoing prevention emphasize fly exposure reduction. Stabling during peak fly activity periods, typically during daylight hours in summer months, significantly reduces exposure. Stalls should be kept clean with fresh bedding to minimize fly attraction. Fans improve air circulation and reduce fly activity within stabled areas. Turnout during early morning, evening, or overnight hours when fly activity decreases provides exercise while limiting exposure. Pasture companions should be compatible and not damage fly protection equipment during mutual grooming or play. Run-in sheds in pastures provide refuge during fly activity peaks.

Exercise modifications during active disease balance maintaining fitness with protecting healing lesions. Horses with active periocular habronemiasis may continue light work as comfort allows, with fly protection maintained during any outdoor activity. Intense exercise generating significant sweat attracts flies and may exacerbate lesions, suggesting moderation during peak disease. Areas with high fly populations should be avoided during riding. Post-exercise care includes immediate stabling or fly mask application before flies accumulate around the sweaty horse. Return to full work follows lesion resolution, though enhanced fly protection should continue throughout fly season.

Monitoring and ongoing care responsibilities extend throughout fly season and across subsequent years for horses with habronemiasis history. Daily visual inspection of periocular areas identifies early recurrence amenable to prompt treatment. Previously affected sites warrant particularly close attention as they demonstrate increased recurrence risk. Documentation through photography provides comparison for detecting subtle changes. Annual veterinary examinations should include discussion of habronemiasis history and prevention strategies. Owners should maintain treatment records including what therapies were effective, facilitating rapid initiation of appropriate treatment if recurrence occurs.

Quality of life and use considerations acknowledge that habronemiasis, while uncomfortable and potentially disfiguring, is manageable in most cases without permanent impact on the horse's usefulness. Active disease causes discomfort that temporarily affects performance and may require rest from competition. Properly treated horses typically return to full function after resolution. Ongoing prevention requirements, particularly fly mask use, represent the primary long-term management burden for owners. Horses in endemic regions may require seasonal prophylactic treatment and enhanced management annually. Despite these requirements, most horses with habronemiasis history enjoy excellent quality of life with appropriate preventive care and remain fully functional for their intended uses.

High-risk populations for periocular habronemiasis relate primarily to environmental exposure rather than specific breed predisposition. Horses of all breeds living in warm, humid climates with high fly populations face elevated risk compared to those in drier or cooler regions. Horses with light pigmentation around the eyes, including those with white facial markings, may show lesions more obviously and potentially demonstrate altered inflammatory responses at non-pigmented sites. Horses with existing ocular conditions, wounds, or irritation providing larval entry sites face increased risk. Those maintained in facilities with poor fly control or abundant fly breeding sites experience greater exposure. Previous habronemiasis at any body site indicates individual susceptibility and increased risk for future episodes.

Use and discipline considerations affect habronemiasis risk primarily through management patterns rather than the activities themselves. Horses maintained outdoors with limited shelter during fly season face greater exposure than stabled horses. Working horses that sweat heavily attract flies and may experience increased periocular moisture supporting larval survival. Horses used during peak fly activity hours encounter more infected flies than those worked during early morning or evening. Show horses may receive more attentive fly management reducing their exposure. Trail horses encountering varied environments may experience exposure to different fly populations. Regardless of discipline, consistent fly protection measures reduce risk across all uses.

Genetic testing and breeding recommendations are not applicable to habronemiasis as this condition results from parasitic infection rather than genetic factors. However, individual variation in hypersensitivity response to Habronema larvae suggests some genetic influence on disease severity once exposure occurs. Horses demonstrating particularly severe responses or frequent recurrence may transmit susceptibility to offspring, though this has not been formally studied in horses. Current prevention recommendations focus entirely on environmental management and fly control rather than genetic selection. Research into genetic factors influencing hypersensitivity responses to parasites might eventually inform breeding decisions, but no practical applications currently exist.

Commonly co-occurring conditions with periocular habronemiasis include cutaneous habronemiasis at other body sites. The same flies transmitting larvae to the periocular region deposit larvae at other moist areas and wounds, creating lesions at the prepuce or vulva, medial canthus of the eye, commissures of the lips, and any existing wounds or moist skin areas. Managing periocular habronemiasis should include examination of the entire horse for additional lesions requiring concurrent treatment. Gastric habronemiasis, the normal parasitic infection in the stomach, exists in most horses in endemic regions but rarely causes clinical signs. Secondary bacterial infection of habronemiasis lesions occurs commonly, requiring concurrent antimicrobial therapy.

Conditions with similar clinical presentation require differentiation for appropriate management. Squamous cell carcinoma represents the most important differential diagnosis, as this malignancy creates similar ulcerated, granulomatous periocular masses and carries significantly different prognosis and treatment requirements. Sarcoids, particularly fibroblastic forms, produce proud flesh-like masses mimicking habronemiasis appearance. Pythiosis creates similar granulomatous lesions with caseous material in similar geographic and environmental conditions, though caused by oomycete organisms rather than nematode larvae. Proud flesh from wounds, fungal granulomas, and eosinophilic granulomas require histopathologic differentiation when clinical presentation is atypical or response to treatment inadequate. Accurate diagnosis through biopsy ensures appropriate therapy.

Potential complications of periocular habronemiasis include local tissue effects and treatment-related problems. Extensive tissue destruction from severe or prolonged disease may cause permanent eyelid scarring, distortion, or dysfunction affecting tear film distribution and corneal protection. Corneal involvement with ulceration or scarring may occur with conjunctival lesions extending onto the corneal surface. Self-trauma from intense pruritus exacerbates lesions and introduces secondary infection. Chronic corticosteroid therapy required for some cases carries risks of laminitis, immune suppression, and other systemic effects. Lesion recurrence represents the most common complication, often occurring at previously affected sites during subsequent fly seasons despite appropriate initial treatment. Rarely, extensive lesions may necessitate surgical reconstruction or, in extreme cases, affect decisions regarding ongoing treatment versus humane euthanasia.